nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—CREB1—telencephalic ventricle—meningioma	0.0639	0.239	CbGeAlD
Naloxone—OPRM1—telencephalic ventricle—meningioma	0.0345	0.129	CbGeAlD
Naloxone—TLR4—cerebellum—meningioma	0.0194	0.0725	CbGeAlD
Naloxone—CREB1—brainstem—meningioma	0.0173	0.0648	CbGeAlD
Naloxone—TLR4—brain—meningioma	0.0157	0.0589	CbGeAlD
Naloxone—CREB1—medulla oblongata—meningioma	0.0121	0.0452	CbGeAlD
Naloxone—CREB1—spinal cord—meningioma	0.0108	0.0403	CbGeAlD
Naloxone—OPRM1—brainstem—meningioma	0.00932	0.0349	CbGeAlD
Naloxone—CREB1—cerebellum—meningioma	0.00853	0.0319	CbGeAlD
Naloxone—CREB1—brain—meningioma	0.00693	0.0259	CbGeAlD
Naloxone—ESR1—brainstem—meningioma	0.00681	0.0255	CbGeAlD
Naloxone—OPRK1—cerebellum—meningioma	0.00646	0.0242	CbGeAlD
Naloxone—OPRM1—spinal cord—meningioma	0.0058	0.0217	CbGeAlD
Naloxone—SLCO1A2—medulla oblongata—meningioma	0.0056	0.021	CbGeAlD
Naloxone—OPRD1—brain—meningioma	0.00547	0.0205	CbGeAlD
Naloxone—OPRK1—brain—meningioma	0.00525	0.0197	CbGeAlD
Naloxone—SLCO1A2—spinal cord—meningioma	0.00499	0.0187	CbGeAlD
Naloxone—SLCO1A2—cerebellum—meningioma	0.00396	0.0148	CbGeAlD
Naloxone—OPRM1—brain—meningioma	0.00373	0.014	CbGeAlD
Naloxone—ESR1—cerebellum—meningioma	0.00336	0.0126	CbGeAlD
Naloxone—SLCO1A2—brain—meningioma	0.00321	0.012	CbGeAlD
Naloxone—ALB—brain—meningioma	0.0032	0.012	CbGeAlD
Naloxone—ESR1—brain—meningioma	0.00273	0.0102	CbGeAlD
Naloxone—CYP2C8—brain—meningioma	0.00225	0.00841	CbGeAlD
Naloxone—CREB1—AP-1 transcription factor network—TP53—meningioma	0.00207	0.00282	CbGpPWpGaD
Naloxone—CREB1—miRNA Regulation of DNA Damage Response—TP53—meningioma	0.00204	0.00279	CbGpPWpGaD
Naloxone—CREB1—Signaling by SCF-KIT—ERBB2—meningioma	0.00203	0.00277	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CTSL—meningioma	0.00203	0.00276	CbGpPWpGaD
Naloxone—ESR1—LKB1 signaling events—TP53—meningioma	0.002	0.00273	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—PTEN—meningioma	0.00198	0.00271	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling of activated FGFR—ERBB2—meningioma	0.00194	0.00265	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB4—ERBB2—meningioma	0.00191	0.0026	CbGpPWpGaD
Naloxone—CREB1—Immune System—AP1B1—meningioma	0.00191	0.0026	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—SMO—meningioma	0.0019	0.00259	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—TSHB—meningioma	0.00189	0.00257	CbGpPWpGaD
Naloxone—ALB—Platelet degranulation—PDGFB—meningioma	0.00188	0.00257	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—ERBB2—meningioma	0.00188	0.00257	CbGpPWpGaD
Naloxone—ABCB1—medulla oblongata—meningioma	0.00187	0.00702	CbGeAlD
Naloxone—ESR1—Signaling by ERBB4—PDGFB—meningioma	0.00187	0.00255	CbGpPWpGaD
Naloxone—CREB1—Oncostatin M Signaling Pathway—AKT1—meningioma	0.00185	0.00253	CbGpPWpGaD
Naloxone—CREB1—TSH signaling pathway—AKT1—meningioma	0.00183	0.0025	CbGpPWpGaD
Naloxone—CREB1—HIF-1-alpha transcription factor network—AKT1—meningioma	0.00183	0.0025	CbGpPWpGaD
Naloxone—CREB1—Downstream signal transduction—ERBB2—meningioma	0.00182	0.00249	CbGpPWpGaD
Naloxone—CREB1—Glucocorticoid receptor regulatory network—TP53—meningioma	0.00182	0.00248	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR—ERBB2—meningioma	0.00181	0.00248	CbGpPWpGaD
Naloxone—CREB1—EGF/EGFR Signaling Pathway—ERBB2—meningioma	0.00181	0.00248	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB2—ERBB2—meningioma	0.00181	0.00246	CbGpPWpGaD
Naloxone—CREB1—DAP12 signaling—ERBB2—meningioma	0.0018	0.00245	CbGpPWpGaD
Naloxone—ALB—Response to elevated platelet cytosolic Ca2+—PDGFB—meningioma	0.00179	0.00245	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—meningioma	0.00177	0.00242	CbGpPWpGaD
Naloxone—CREB1—SREBP signalling—AKT1—meningioma	0.00176	0.00241	CbGpPWpGaD
Naloxone—CREB1—Disease—AP1B1—meningioma	0.00176	0.0024	CbGpPWpGaD
Naloxone—ESR1—Plasma membrane estrogen receptor signaling—AKT1—meningioma	0.00175	0.00239	CbGpPWpGaD
Naloxone—CREB1—Signaling by SCF-KIT—PTEN—meningioma	0.00173	0.00236	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—PDGFB—meningioma	0.00172	0.00234	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—ERBB2—meningioma	0.00169	0.00231	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR in disease—ERBB2—meningioma	0.00169	0.00231	CbGpPWpGaD
Naloxone—CREB1—DAP12 interactions—ERBB2—meningioma	0.00169	0.00231	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR—ERBB2—meningioma	0.00168	0.00229	CbGpPWpGaD
Naloxone—ABCB1—spinal cord—meningioma	0.00167	0.00626	CbGeAlD
Naloxone—CREB1—Signaling by EGFR in Cancer—ERBB2—meningioma	0.00166	0.00227	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling of activated FGFR—PTEN—meningioma	0.00165	0.00226	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—ERBB2—meningioma	0.00165	0.00226	CbGpPWpGaD
Naloxone—CREB1—Leptin signaling pathway—AKT1—meningioma	0.00165	0.00225	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—PTEN—meningioma	0.00164	0.00223	CbGpPWpGaD
Naloxone—TLR4—Immune System—PDGFB—meningioma	0.00163	0.00223	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—meningioma	0.00163	0.00223	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB4—PTEN—meningioma	0.00163	0.00222	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—PTEN—meningioma	0.0016	0.00219	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—SMO—meningioma	0.0016	0.00219	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.00159	0.00217	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—ERBB2—meningioma	0.00156	0.00213	CbGpPWpGaD
Naloxone—CREB1—Downstream signal transduction—PTEN—meningioma	0.00155	0.00212	CbGpPWpGaD
Naloxone—CREB1—Regulation of nuclear SMAD2/3 signaling—AKT1—meningioma	0.00155	0.00212	CbGpPWpGaD
Naloxone—CREB1—EGF/EGFR Signaling Pathway—PTEN—meningioma	0.00155	0.00211	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR—PTEN—meningioma	0.00155	0.00211	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB2—PTEN—meningioma	0.00154	0.0021	CbGpPWpGaD
Naloxone—CREB1—Glucocorticoid receptor regulatory network—AKT1—meningioma	0.00154	0.0021	CbGpPWpGaD
Naloxone—CREB1—DAP12 signaling—PTEN—meningioma	0.00153	0.00209	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling events of B Cell Receptor (BCR)—PTEN—meningioma	0.00151	0.00206	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—ERBB2—meningioma	0.0015	0.00204	CbGpPWpGaD
Naloxone—CREB1—Constitutive PI3K/AKT Signaling in Cancer—AKT1—meningioma	0.00148	0.00202	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—meningioma	0.00147	0.002	CbGpPWpGaD
Naloxone—CREB1—Signaling by NOTCH—TP53—meningioma	0.00145	0.00198	CbGpPWpGaD
Naloxone—CREB1—DAP12 interactions—PTEN—meningioma	0.00144	0.00197	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR in disease—PTEN—meningioma	0.00144	0.00197	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—PTEN—meningioma	0.00144	0.00197	CbGpPWpGaD
Naloxone—CREB1—Androgen receptor signaling pathway—AKT1—meningioma	0.00144	0.00196	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—TSHB—meningioma	0.00144	0.00196	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR—PTEN—meningioma	0.00143	0.00195	CbGpPWpGaD
Naloxone—CREB1—TCR Signaling Pathway—AKT1—meningioma	0.00143	0.00195	CbGpPWpGaD
Naloxone—OPRM1—IL4-mediated signaling events—AKT1—meningioma	0.00142	0.00194	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR in Cancer—PTEN—meningioma	0.00142	0.00193	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—PTEN—meningioma	0.00141	0.00192	CbGpPWpGaD
Naloxone—CREB1—Corticotropin-releasing hormone—AKT1—meningioma	0.0014	0.00191	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.00136	0.00185	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—TP53—meningioma	0.00135	0.00185	CbGpPWpGaD
Naloxone—CREB1—B Cell Receptor Signaling Pathway—AKT1—meningioma	0.00134	0.00183	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—PTEN—meningioma	0.00133	0.00182	CbGpPWpGaD
Naloxone—CREB1—PI-3K cascade—AKT1—meningioma	0.00133	0.00182	CbGpPWpGaD
Naloxone—ABCB1—cerebellum—meningioma	0.00133	0.00496	CbGeAlD
Naloxone—ESR1—Generic Transcription Pathway—PGR—meningioma	0.00132	0.0018	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—TSHB—meningioma	0.00131	0.00179	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—TSHB—meningioma	0.00131	0.00178	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—PTEN—meningioma	0.0013	0.00178	CbGpPWpGaD
Naloxone—CREB1—PI3K/AKT activation—AKT1—meningioma	0.0013	0.00178	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—HES1—meningioma	0.0013	0.00177	CbGpPWpGaD
Naloxone—CREB1—GAB1 signalosome—AKT1—meningioma	0.00129	0.00176	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD34—meningioma	0.00129	0.00176	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—PTEN—meningioma	0.00128	0.00174	CbGpPWpGaD
Naloxone—CREB1—ErbB1 downstream signaling—AKT1—meningioma	0.00126	0.00172	CbGpPWpGaD
Naloxone—CREB1—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—meningioma	0.00126	0.00172	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—TSHB—meningioma	0.00126	0.00172	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—ERBB2—meningioma	0.00125	0.00171	CbGpPWpGaD
Naloxone—CREB1—Immune System—CTSL—meningioma	0.00123	0.00168	CbGpPWpGaD
Naloxone—ESR1—Regulation of Telomerase—AKT1—meningioma	0.00117	0.0016	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—ALAD—meningioma	0.00116	0.00159	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—ERBB2—meningioma	0.00115	0.00157	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—TSHB—meningioma	0.00115	0.00156	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—TP53—meningioma	0.00112	0.00152	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—SMO—meningioma	0.00111	0.00152	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—SMO—meningioma	0.00111	0.00152	CbGpPWpGaD
Naloxone—TLR4—Immune System—ERBB2—meningioma	0.0011	0.0015	CbGpPWpGaD
Naloxone—ESR1—Leptin signaling pathway—AKT1—meningioma	0.00108	0.00148	CbGpPWpGaD
Naloxone—ABCB1—brain—meningioma	0.00108	0.00403	CbGeAlD
Naloxone—ESR1—Integrated Breast Cancer Pathway—PTEN—meningioma	0.00107	0.00146	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—PTEN—meningioma	0.00107	0.00145	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—TSHB—meningioma	0.00107	0.00145	CbGpPWpGaD
Naloxone—OPRM1—TCR Signaling Pathway—AKT1—meningioma	0.00105	0.00144	CbGpPWpGaD
Naloxone—CREB1—Disease—CST3—meningioma	0.00105	0.00143	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—ERBB2—meningioma	0.00104	0.00142	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.00104	0.00142	CbGpPWpGaD
Naloxone—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—meningioma	0.00102	0.00139	CbGpPWpGaD
Naloxone—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—meningioma	0.001	0.00137	CbGpPWpGaD
Naloxone—CREB1—Signaling by SCF-KIT—AKT1—meningioma	0.000996	0.00136	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—PTEN—meningioma	0.000982	0.00134	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—PDGFB—meningioma	0.00098	0.00134	CbGpPWpGaD
Naloxone—CREB1—BDNF signaling pathway—AKT1—meningioma	0.00098	0.00134	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—SMO—meningioma	0.000974	0.00133	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—TSHB—meningioma	0.000968	0.00132	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling of activated FGFR—AKT1—meningioma	0.000953	0.0013	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—AKT1—meningioma	0.000943	0.00129	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—PDGFB—meningioma	0.000941	0.00128	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB4—AKT1—meningioma	0.000938	0.00128	CbGpPWpGaD
Naloxone—TLR4—Immune System—PTEN—meningioma	0.000934	0.00127	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.000926	0.00126	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—AKT1—meningioma	0.000925	0.00126	CbGpPWpGaD
Naloxone—CREB1—Downstream signal transduction—AKT1—meningioma	0.000896	0.00122	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR—AKT1—meningioma	0.000892	0.00122	CbGpPWpGaD
Naloxone—CREB1—EGF/EGFR Signaling Pathway—AKT1—meningioma	0.000892	0.00122	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—TP53—meningioma	0.000889	0.00121	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.000888	0.00121	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB2—AKT1—meningioma	0.000887	0.00121	CbGpPWpGaD
Naloxone—CREB1—DAP12 signaling—AKT1—meningioma	0.000883	0.0012	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.00087	0.00119	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—TP53—meningioma	0.000857	0.00117	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—PDGFB—meningioma	0.000835	0.00114	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.000831	0.00113	CbGpPWpGaD
Naloxone—CREB1—DAP12 interactions—AKT1—meningioma	0.000831	0.00113	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR in disease—AKT1—meningioma	0.000831	0.00113	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR—AKT1—meningioma	0.000823	0.00112	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—SMO—meningioma	0.000823	0.00112	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR in Cancer—AKT1—meningioma	0.000816	0.00111	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—AKT1—meningioma	0.000812	0.00111	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000782	0.00107	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TSHB—meningioma	0.000774	0.00106	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TSHB—meningioma	0.000772	0.00105	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—AKT1—meningioma	0.000769	0.00105	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—TSHB—meningioma	0.000749	0.00102	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—ERBB2—meningioma	0.000744	0.00101	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.000736	0.001	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—TP53—meningioma	0.000732	0.000998	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TSHB—meningioma	0.000677	0.000923	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—SMO—meningioma	0.000658	0.000898	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—ERBB2—meningioma	0.000657	0.000896	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—SMO—meningioma	0.000656	0.000895	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—PGR—meningioma	0.000636	0.000867	CbGpPWpGaD
Naloxone—ABCB1—HIF-1-alpha transcription factor network—AKT1—meningioma	0.000634	0.000865	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—PGR—meningioma	0.000631	0.000861	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—ERBB2—meningioma	0.000631	0.00086	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PGR—meningioma	0.000629	0.000858	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—AKT1—meningioma	0.000618	0.000843	CbGpPWpGaD
Naloxone—CREB1—Disease—HES1—meningioma	0.000616	0.000841	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—AKT1—meningioma	0.000615	0.000839	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.000606	0.000827	CbGpPWpGaD
Naloxone—ALB—Hemostasis—PLAUR—meningioma	0.000595	0.000812	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—SMO—meningioma	0.000575	0.000785	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TSHB—meningioma	0.000572	0.00078	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ALAD—meningioma	0.000571	0.00078	CbGpPWpGaD
Naloxone—CREB1—Immune System—PDGFB—meningioma	0.000571	0.000779	CbGpPWpGaD
Naloxone—ALB—Metabolism—ALAD—meningioma	0.000568	0.000775	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—AKT1—meningioma	0.000566	0.000772	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—PTEN—meningioma	0.00056	0.000764	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PGR—meningioma	0.000552	0.000753	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.000551	0.000752	CbGpPWpGaD
Naloxone—TLR4—Immune System—AKT1—meningioma	0.000538	0.000735	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—PTEN—meningioma	0.000538	0.000734	CbGpPWpGaD
Naloxone—CREB1—Disease—PDGFB—meningioma	0.000527	0.000719	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000512	0.000698	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TSHB—meningioma	0.000507	0.000692	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ALAD—meningioma	0.000498	0.000679	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—SMO—meningioma	0.000486	0.000663	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.00047	0.000641	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PGR—meningioma	0.000466	0.000636	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000458	0.000626	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—HES1—meningioma	0.000431	0.000589	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—SMO—meningioma	0.000431	0.000588	CbGpPWpGaD
Naloxone—ALB—Hemostasis—PDGFB—meningioma	0.00043	0.000587	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—HES1—meningioma	0.00043	0.000587	CbGpPWpGaD
Naloxone—ALB—Hemostasis—PLAU—meningioma	0.000418	0.00057	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PGR—meningioma	0.000413	0.000564	CbGpPWpGaD
Naloxone—CREB1—Immune System—ERBB2—meningioma	0.000383	0.000522	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—HES1—meningioma	0.000377	0.000514	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—PDGFB—meningioma	0.000369	0.000503	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—TSHB—meningioma	0.000368	0.000502	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PDGFB—meningioma	0.000368	0.000502	CbGpPWpGaD
Naloxone—ALB—Metabolism—TSHB—meningioma	0.000366	0.0005	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—AKT1—meningioma	0.000365	0.000499	CbGpPWpGaD
Naloxone—CREB1—Disease—ERBB2—meningioma	0.000353	0.000482	CbGpPWpGaD
Naloxone—CREB1—Immune System—PTEN—meningioma	0.000326	0.000445	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—AKT1—meningioma	0.000323	0.00044	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PDGFB—meningioma	0.000323	0.00044	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—TSHB—meningioma	0.000321	0.000438	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.000321	0.000438	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—HES1—meningioma	0.000319	0.000435	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—AKT1—meningioma	0.00031	0.000423	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ALAD—meningioma	0.000307	0.000419	CbGpPWpGaD
Naloxone—CREB1—Disease—PTEN—meningioma	0.000301	0.000411	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—HES1—meningioma	0.000283	0.000386	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000275	0.000375	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PDGFB—meningioma	0.000273	0.000372	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000271	0.00037	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—ERBB2—meningioma	0.000247	0.000337	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—ERBB2—meningioma	0.000247	0.000336	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PDGFB—meningioma	0.000242	0.00033	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—AKT1—meningioma	0.000226	0.000308	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000225	0.000307	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000224	0.000306	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—ERBB2—meningioma	0.000216	0.000295	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—PTEN—meningioma	0.000211	0.000288	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PTEN—meningioma	0.00021	0.000287	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—AKT1—meningioma	0.000206	0.000281	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—AKT1—meningioma	0.000205	0.00028	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PTEN—meningioma	0.000204	0.000279	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—AKT1—meningioma	0.000198	0.00027	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—TSHB—meningioma	0.000198	0.00027	CbGpPWpGaD
Naloxone—CREB1—Immune System—AKT1—meningioma	0.000188	0.000256	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PTEN—meningioma	0.000184	0.000252	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—ERBB2—meningioma	0.000183	0.000249	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—AKT1—meningioma	0.00018	0.000245	CbGpPWpGaD
Naloxone—CREB1—Disease—AKT1—meningioma	0.000174	0.000237	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TP53—meningioma	0.000168	0.000229	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—AKT1—meningioma	0.000167	0.000228	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—ERBB2—meningioma	0.000162	0.000221	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PTEN—meningioma	0.000156	0.000213	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—AKT1—meningioma	0.000152	0.000207	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TP53—meningioma	0.000144	0.000196	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TP53—meningioma	0.000143	0.000196	CbGpPWpGaD
Naloxone—ALB—Hemostasis—AKT1—meningioma	0.000142	0.000193	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PTEN—meningioma	0.000138	0.000188	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TP53—meningioma	0.000126	0.000172	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—AKT1—meningioma	0.000122	0.000167	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—AKT1—meningioma	0.000122	0.000166	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—AKT1—meningioma	0.000121	0.000165	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—AKT1—meningioma	0.000118	0.000161	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TP53—meningioma	0.000106	0.000145	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—AKT1—meningioma	0.000106	0.000145	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PTEN—meningioma	0.0001	0.000137	CbGpPWpGaD
Naloxone—ALB—Metabolism—PTEN—meningioma	9.98e-05	0.000136	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TP53—meningioma	9.43e-05	0.000129	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—AKT1—meningioma	8.98e-05	0.000122	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PTEN—meningioma	8.74e-05	0.000119	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—AKT1—meningioma	7.96e-05	0.000109	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—AKT1—meningioma	5.78e-05	7.89e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—AKT1—meningioma	5.75e-05	7.84e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PTEN—meningioma	5.39e-05	7.35e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—AKT1—meningioma	5.04e-05	6.87e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—AKT1—meningioma	3.1e-05	4.23e-05	CbGpPWpGaD
